Exploring if Intranasal Therapies Deliver Clinical Benefit Without Direct Systemic Exposure
9:00 am - Wednesday 3rd February 2027
- Explore alternative mechanisms through which intranasal therapies may influence CNS pathways and clinical outcomes
- Understand how clinical and translational evidence can support novel nasal mechanisms without relying solely on traditional pharmacokinetic approaches
- Examine lessons learned from developing intranasal therapies targeting neurological and psychiatric disorders
